Press release
Pericarditis Market Estimation 2018 by Top Leading Players - Pfizer Inc. (U.S.), AstraZeneca (U.S.), Bayer AG (Europe), Reckitt Benckiser Group plc. (Europe), PerkinElmer, Inc. (U.S.) Outlook 2023 – MarketResearchFuture.com
Global Pericarditis Market -Synopsis
According to a new report by Market Research Future, the global market for pericarditis is estimated to expand at a striking 7.5% CAGR during the forecast period (2017-2023) due to the adoption and growing awareness of anti-inflammatory drugs. Pericarditis is a condition of irritation and swelling of the pericardium sac and can lead to heart palpitations and chest pain.
While acute pericarditis does not last long, chronic pericarditis lasts for weeks to months. Treatment might include medication and surgery in case of chronic pericarditis. According to the American Heart Association, the growing geriatric population is more susceptible to pericarditis.
Global Pericarditis Market -Drivers and Constraints Impacting the Growth
Increasing prevalence of cardiovascular diseases, growing geriatric population, and rising healthcare are some of the major factors driving the market growth for pericarditis globally. Several autoimmune diseases, rising cases of heart attack, changing lifestyle, rapid urbanization, advantages of botanical drugs over other drugs, treatment of illness, improvement in reimbursement policies, and several other are some of the push factors.
Moreover, the rapid industrialization, constant innovations, burgeoning demands, technological advancements, growth of the medical sector, and rise in expenditure in R&D are some of the other factors fueling the market growth during the assessment period. Also, concerned manufacturers are taking up joint ventures, partnerships, and acquisitions as their key policies which is further contributing to the inorganic growth of the market.
Request Sample with New Market Trends @ https://www.marketresearchfuture.com/sample_request/1847
Global Pericarditis Market - Segmentation
The global pericarditis has been segmented on the basis of diagnosis, type, treatment, end-users, and region.
The market has been segmented into chronic, acute, recurrent pericarditis, and others based on type.
The market has been segmented into blood test, echocardiogram, electrocardiogram, X-ray, and others based on diagnosis. While the electro gram segment is subdivided into ECG, EKG, and others, the echocardiogram segment is subdivided into transesophageal echocardiogram, transthoracic echocardiogram, stress echocardiogram, and others.
The market has also been segmented into surgical, pharmacological, and others based on treatment. The pharmacological segment is sub-segmented into colchicine, non-steroidal anti-inflammatory drugs, and others. The non-steroidal anti-inflammatory is again sub-segmented into ibuprofen, aspirin, and others. Also, the surgical segment is subdivided into pericardiocentesis, pericardiectomy, pericardiotomy, and others. The market has been segmented into medical institutes, hospitals & clinics, research organization, and others.
Global Pericarditis Market -Competition Analysis
The prominent players operating the market for global pericarditis are
Pfizer Inc. (U.S.)
Reckitt Benckiser Group Plc. (Europe)
FUJIFILM Holdings Corporation (Asia Pacific)
Merck Sharp & Dohme Corp. (U.S.)
Bayer AG (Europe)
AstraZeneca (U.S.)
ALLERGAN (Europe)
PerkinElmer Inc. (U.S.)
Obtain Report Details with Technological Advancement @ https://www.marketresearchfuture.com/reports/pericarditis-market-1847
North America to Dominate the Market
Geographically, the market for pericarditis has been spanned across North America, Europe, Asia Pacific, and the Middle East and Africa. North America is anticipated to dominate the global market for pericarditis owing to the increasing patient population for cardiovascular diseases, rising healthcare expenditure, and growing geriatric population. According to Centers for Disease Control and Prevention, the total expenditure for health care in the U.S. accounted for 17.8 % of the total gross product.
Europe holds the second largest position and is closely followed by the Asia Pacific market. Growing expenditure for health care, availability of funds for R&D, and high patient population are some of the major drivers for this market in this region.
Global Pericarditis Market -Industry News
KEYTRUDA, Merck’s anti-PD-1 therapy had been approved by the China National Drug Administration for the treatment of patients suffering from metastatic melanoma or unrespectable, as declared by Kenilworth, known as MSD outside the US. This is the only and the first approval of anti-PD-1 therapy for advanced melanoma in the China region.
Major Points form Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Pericarditis Market, By Type
Chapter 7. Global Pericarditis Market, By Treatment
Chapter 8 Global Pericarditis Market, By End User
Chapter 9. Global Pericarditis Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Get Excusive Discount @ https://www.marketresearchfuture.com/check-discount/1847
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pericarditis Market Estimation 2018 by Top Leading Players - Pfizer Inc. (U.S.), AstraZeneca (U.S.), Bayer AG (Europe), Reckitt Benckiser Group plc. (Europe), PerkinElmer, Inc. (U.S.) Outlook 2023 – MarketResearchFuture.com here
News-ID: 1230443 • Views: …
More Releases from Market Research Future
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics.
The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over…
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more.
The Palm Methyl Ester Derivative Market Size was valued at USD 1.5…
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences.
Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2…
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further.
APAC Wallpaper Market Size was valued at USD 0.55…
More Releases for Pericarditis
Pericarditis Treatment Market Overview, High Growth Opportunities, Segmentation, …
Global pericarditis treatment market is likely to be worth US$ 3.60 Billion in 2022, and is anticipated to grow at a CAGR of 5.24% during the projected period, reaching US$ 6 Billion by 2032. Pericarditis is a cardiovascular disease which represents the swelling of the pericardium wall of the heart. The main cause of pericardium disease is the inflammation of pericardium wall which is generally caused by viral infection. Other…
Pericarditis Drugs Market Size to Expand Significantly by the End of 2027
Pericarditis Drugs Market Introduction
Pericarditis is the inflammation of the pericardium. Pericardium is two thin layers of a sac like structure of tissues that surrounds the heart. The pericardium holds the heart in place and helps it work. It is a small amount of fluid that keeps both the layers separated from each other so that there is no friction between the layers. Pericarditis often causes chest pain and other symptoms…
Pericarditis Treatment Market Key Manufacturers Analysis 2019 Industry Size by T …
Pericarditis is a cardiovascular disease which represents the swelling of the pericardium wall of the heart. The main cause of pericardium disease is the inflammation of pericardium wall which is generally caused by viral infection. Other causes of pericarditis disease are renal failure, bacterial infections and intake of some drugs such as procainamide.
Pericarditis Treatment Industry Scrutinized The increasing prevalence of cardiovascular diseases such as heart attack & hypertension, favorable reimbursement…
Pericarditis Drugs Market Scope, Demand, Supply and Key Manufacturers Analysis b …
“Pericarditis Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.
Pericarditis is an inflammation of pericardium. It is the inflammation that occurs around the lining of the heart causing chest pain and accumulation of fluid around the pericardial effusion. There may…
Pericarditis Drugs Market Overview and Regional Outlook Study 2018 – 2028
Global Pericarditis Drugs Market: Overview
The demand within the global pericarditis drugs market has been rising on account of advancements in the field of cardiac treatments. The availability of pericarditis drugs is a positive sign for the pharmaceutical industry, and this factor has played a key role in market growth. There have been key advancements in the healthcare sector with regard to treatment and diagnosis of cardiovascular diseases. Pericarditis is…
Pericarditis Market Size is set for Rapid Growth 2019 | Pfizer, Astrazeneca, Bay …
The Global Pericarditis market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Pericarditis Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Pericarditis market.…
